Phase I/IIa Study of SNK01 in Participants With Moderate Alzheimer ' s Disease

Conditions: Moderate Alzheimer Disease Interventions: Biological: SNK01; Other: Placebo Sponsors: NKGen Biotech, Inc. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials